Portal:Nanomaterials/PathwayList
From WikiPathways
(Difference between revisions)
Current revision (16:13, 6 March 2023) (view source) |
|||
| (One intermediate revision not shown.) | |||
| Line 5: | Line 5: | ||
* [[Pathway:WP3287|Overview of nanoparticle effects]] | * [[Pathway:WP3287|Overview of nanoparticle effects]] | ||
* [[Pathway:WP3624|Lung fibrosis (Homo sapiens)]] and [[Pathway:WP3632|(Mus musculus)]] | * [[Pathway:WP3624|Lung fibrosis (Homo sapiens)]] and [[Pathway:WP3632|(Mus musculus)]] | ||
| + | * [[Pathway:WP3890|Nanomaterial induced inflammasome activation (Homo sapiens)]] | ||
| + | * [[Pathway:WP5336|Induction of autophagy and toll-like receptor signaling pathways by graphene oxide]] | ||
Current revision
- Nanomaterial induced apoptosis
- Nanoparticle triggered autophagic cell death
- Nanoparticle triggered regulated necrosis
- Nanoparticle-mediated activation of receptor signaling
- Overview of nanoparticle effects
- Lung fibrosis (Homo sapiens) and (Mus musculus)
- Nanomaterial induced inflammasome activation (Homo sapiens)
- Induction of autophagy and toll-like receptor signaling pathways by graphene oxide
